We are live on ! Find out more
FI

Fosun International Portfolio holdings

AUM $399M
1-Year Est. Return 16.11%
This Fund
S&P 500
This Quarter Est. Return
+12.61%
1 Year Est. Return
-16.11%
3 Year Est. Return
+16.92%
5 Year Est. Return
-0.68%
10 Year Est. Return
+98.52%
AUM
$1.57B
AUM Growth
-$99.9M
Cap. Flow
-$270M
Cap. Flow %
-17.18%
Top 10 Hldgs %
52.85%
Holding
344
New
45
Increased
88
Reduced
69
Closed
37

Top Buys

Rank Stock Value
1
BZUN
Baozun
BZUN
+$17.1M
2
MOMO
Hello Group
MOMO
+$5.31M
3
HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
+$4.25M
4
BMY icon
Bristol-Myers Squibb
BMY
+$4.13M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$3.26M

Top Sells

Rank Stock Value
1
KANG
iKang Healthcare Group, Inc.
KANG
+$94.3M
2
VIPS icon
Vipshop
VIPS
+$47.3M
3
DBRG icon
DigitalBridge
DBRG
+$39.3M
4
BKD icon
Brookdale Senior Living
BKD
+$37.8M
5
CRTO icon
Criteo S.A. Ordinary Shares
CRTO
+$15.3M

Sector Composition

Rank Sector Weight
1 Healthcare 37.62%
2 Financials 6.46%
3 Consumer Discretionary 4.13%
4 Industrials 2.9%
5 Communication Services 2.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZGNX
76
DELISTED
Zogenix, Inc.
ZGNX
$2.49M 0.16%
45,700
– –
QTNT
77
DELISTED
Quotient Limited Ordinary Shares
QTNT
$2.45M 0.16%
+6,831
New +$2.4M
RARX
78
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$2.42M 0.15%
108,073
– –
TBPH icon
79
Theravance Biopharma
TBPH
$873M
$2.39M 0.15%
+104,465
New +$2.65M
ABT icon
80
Abbott
ABT
$187B
$2.37M 0.15%
29,885
– –
SQM icon
81
Sociedad Química y Minera de Chile
SQM
$19.3B
$2.35M 0.15%
62,000
+5,000
+9% +$204K
WVE icon
82
Wave Life Sciences
WVE
$1.12B
$2.24M 0.14%
+59,088
New +$2.4M
PYPL icon
83
PayPal
PYPL
$49.9B
$2.19M 0.14%
21,058
+2,038
+11% +$193K
PGNX
84
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$2.17M 0.14%
472,580
+17,992
+4% +$81.4K
OPK icon
85
Opko Health
OPK
$1.02B
$2.17M 0.14%
858,142
+90,000
+12% +$273K
EIDX
86
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$2.17M 0.14%
94,270
– –
GRMN
87
Garmin
GRMN
$56.9B
$2.14M 0.14%
25,000
-12,700
-34% -$956K
ANAB icon
88
AnaptysBio
ANAB
$1.54B
$2.12M 0.13%
30,696
+9,100
+42% +$628K
SBUX icon
89
Starbucks
SBUX
$119B
$2.1M 0.13%
28,425
+14,825
+109% +$1.02M
VTRS icon
90
Viatris
VTRS
$20.8B
$2.07M 0.13%
73,160
-38,631
-35% -$1.13M
KALV
91
DELISTED
KalVista Pharmaceuticals
KALV
$2.03M 0.13%
72,606
-64,837
-47% -$1.41M
UBS icon
92
UBS Group
UBS
$170B
$2.02M 0.13%
+170,925
New +$2.16M
BBWI icon
93
Bath & Body Works
BBWI
$3.97B
$1.99M 0.13%
89,250
-515,764
-85% -$11.3M
CYTK icon
94
Cytokinetics
CYTK
$10.6B
$1.98M 0.13%
239,792
+62,000
+35% +$456K
EIGR
95
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$1.97M 0.13%
4,840
-1,220
-20% -$490K
AAPL icon
96
Apple
AAPL
$4.97T
$1.92M 0.12%
40,628
-8,372
-17% -$355K
KALA icon
97
KALA BIO
KALA
$12.5M
$1.9M 0.12%
99
– –
MRK icon
98
Merck
MRK
$322B
$1.84M 0.12%
23,297
-68,801
-75% -$5.15M
BLK icon
99
Blackrock
BLK
$167B
$1.82M 0.12%
4,290
+3,640
+560% +$1.53M
SLG icon
100
SL Green Realty
SLG
$3.83B
$1.8M 0.11%
20,660
– –
2 3
4
5 6

Similar funds

NC
NovaPoint Capital Atlanta, Georgia $399M AUM 26.97% 1-Year Est. Return
T2I
Turim 21 Investimentos Rio De Janeiro, Brazil $399M AUM 20.13% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
IAA
Ironsides Asset Advisors Rocky Mount, North Carolina $399M AUM 13.99% 1-Year Est. Return
THL
Tillman Hartley LLC Denver, Colorado $398M AUM 16.44% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $398M AUM 23.9% 1-Year Est. Return
BWM
BCGM Wealth Management Lafayette, Indiana $398M AUM 17.85% 1-Year Est. Return
KHCM
Kettle Hill Capital Management New York $399M AUM 10.05% 1-Year Est. Return

Fosun International's Q1 2019 Portfolio in Review

As of Q1 2019, Fosun International held 344 positions worth $1.57B, down 6% from $1.67B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Fosun International withdrew a net $270M in Q1 2019, closing 37 positions and reducing 69 holdings. Its most notable exit was iKang Healthcare Group, Inc., an estimated $94.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 39% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Fosun International opened a new position in Baozun worth $20.3M.

  • Fosun International's largest Q1 2019 buy was Baozun: 488,992 shares worth $20.3M.
  • Fosun International added most to Neurocrine Biosciences in Q1 2019, an estimated $3.26M increase.
  • Fosun International's biggest Q1 2019 reduction was Vipshop, cutting an estimated $47.3M.
  • Fosun International fully exited iKang Healthcare Group, Inc. in Q1 2019, selling an estimated $94.3M.
  • Fosun International's ten largest holdings make up 53% of its $1.57B portfolio in Q1 2019.
  • Fosun International opened 45 new positions and closed 37 in Q1 2019.
  • Fosun International's portfolio value fell 6% quarter-over-quarter to $1.57B.

Based on Fosun International's 13F filing for Q1 2019, filed 10 May 2019.